ZA92663B - Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors. - Google Patents

Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors.

Info

Publication number
ZA92663B
ZA92663B ZA92663A ZA92663A ZA92663B ZA 92663 B ZA92663 B ZA 92663B ZA 92663 A ZA92663 A ZA 92663A ZA 92663 A ZA92663 A ZA 92663A ZA 92663 B ZA92663 B ZA 92663B
Authority
ZA
South Africa
Prior art keywords
treating
soft tissue
pharmaceutical formulation
tissue tumors
diagnosing soft
Prior art date
Application number
ZA92663A
Other languages
English (en)
Inventor
David A Wilson
R Keith Frank
Joseph R Garlich
Jaime Simon
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of ZA92663B publication Critical patent/ZA92663B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA92663A 1991-01-30 1992-01-30 Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors. ZA92663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/648,663 US5308606A (en) 1991-01-30 1991-01-30 Method of treating and/or diagnosing soft tissue tumors

Publications (1)

Publication Number Publication Date
ZA92663B true ZA92663B (en) 1993-07-30

Family

ID=24601702

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92663A ZA92663B (en) 1991-01-30 1992-01-30 Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors.

Country Status (17)

Country Link
US (1) US5308606A (de)
EP (1) EP0499098B1 (de)
JP (1) JPH05505629A (de)
KR (1) KR100219965B1 (de)
AT (1) ATE216266T1 (de)
AU (1) AU650944B2 (de)
CA (1) CA2060332A1 (de)
DE (1) DE69232554T2 (de)
FI (1) FI924363A (de)
IE (1) IE920311A1 (de)
IL (1) IL100800A (de)
MX (1) MX9200413A (de)
NZ (1) NZ241463A (de)
SG (1) SG45366A1 (de)
TW (1) TW205509B (de)
WO (1) WO1992013571A1 (de)
ZA (1) ZA92663B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739313A (en) 1995-11-13 1998-04-14 Regents Of The University Of Minnesota Radionuclide labeling of vitamin B12 and coenzymes thereof
US6806363B1 (en) * 1999-04-16 2004-10-19 Mayo Foundation For Medical Education & Research Cobalamin conjugates useful as antitumor agents
EP1239887A1 (de) 1999-10-15 2002-09-18 Mayo Foundation For Medical Education And Research Cobalamin-konjugate geeignet zur verwendung wie bilderzeugungs- oder therapeutische mitteln
US7591995B2 (en) * 1999-10-15 2009-09-22 Mayo Foundation For Medical Education And Research Cobalamin conjugates useful as imaging and therapeutic agents
WO2001028592A1 (en) * 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Cobalamin conjugates useful as imaging agents and as antitumor agents
AU2002243438A1 (en) * 2000-10-25 2002-07-24 Mayo Foundation For Medical Education And Research Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
US20030018009A1 (en) * 2001-06-20 2003-01-23 Collins Douglas A. Adenosyl-cobalamin fortified compositions
US20060074034A1 (en) * 2001-09-17 2006-04-06 Collins Douglas A Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
EP1435973A4 (de) * 2001-09-28 2007-05-02 Mayo Foundation Gleichzeitige verabreichung eines transportproteins mit konjugiertem cobalamin zur abgabe von mitteln
KR100440725B1 (ko) * 2002-06-20 2004-07-15 주식회사 그린진 바이오텍 비생물성 스트레스에 대한 단자엽 식물의 내성을증가시키는 방법
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
US7419654B2 (en) * 2004-10-08 2008-09-02 Mrinal K. Dewanjee Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents
BRPI0610419A2 (pt) * 2005-05-17 2012-10-23 Cargill Inc lecitina granular, lisolecitina, processo para produzir lecitina granular, composição granular, processo para produzir uma composição de lecitina granular, produto, e, processos para produzir lisolecitina granular e para produzir uma composição de lisolecitina granular

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US421452A (en) * 1890-02-18 Island
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
DE3577550D1 (de) * 1984-09-21 1990-06-13 Dow Chemical Co Aminocarbonsaeurekomplexe zur behandlung von knochentumoren.
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
NZ222304A (en) * 1987-05-18 1990-10-26 Dow Chemical Co Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes

Also Published As

Publication number Publication date
KR100219965B1 (ko) 1999-09-01
AU650944B2 (en) 1994-07-07
WO1992013571A1 (en) 1992-08-20
DE69232554T2 (de) 2002-08-08
FI924363A0 (fi) 1992-09-29
MX9200413A (es) 1992-08-01
IL100800A (en) 1996-10-31
IL100800A0 (en) 1992-09-06
IE920311A1 (en) 1992-07-29
US5308606A (en) 1994-05-03
FI924363A (fi) 1992-09-29
KR930700163A (ko) 1993-03-13
EP0499098A2 (de) 1992-08-19
EP0499098A3 (en) 1992-08-26
TW205509B (de) 1993-05-11
DE69232554D1 (de) 2002-05-23
JPH05505629A (ja) 1993-08-19
AU1054392A (en) 1992-08-06
ATE216266T1 (de) 2002-05-15
CA2060332A1 (en) 1992-07-31
EP0499098B1 (de) 2002-04-17
NZ241463A (en) 2000-01-28
SG45366A1 (en) 1998-01-16

Similar Documents

Publication Publication Date Title
ZA92663B (en) Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors.
ATE51759T1 (de) Hyperthermie-apparat.
EP0350230A3 (en) Immunoconjugates for cancer diagnosis and therapy
AU6357186A (en) An endoscope for guiding radiation light rays for use in medical treatment
AU5299393A (en) Low-power x-ray source with implantable probe for treatment of brain tumors
AU1000488A (en) A light ray radiation device for use in medical treatment of the nose and throat passages
BR9914969A (pt) Métodos para formar imagem, tratar e localizar tecido doente, e, dispositivo integrado de formação de imagem e de tratamento
IE900250L (en) Immunogenic compositions against gastrin peptides
DE3682780D1 (de) Mittel fuer die diagnose, die abbildung, die lokalisierung oder die behandlung von tumoren.
ZA824983B (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
GR3006236T3 (de)
EP0280135A3 (en) Protein c-inhibitor (pci) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing pci
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
EP0471790A4 (en) Method for localization and treatment of tumors and complexes therefor
ZA92664B (en) Compositions and method for soft tissue tumors.
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
Dvivedi Brachytherapy with cathetron-clinical experiences
IT8819818A0 (it) Metodo per il controllo quantitativo del mutamento di posizione o il riposizionamento di pazienti nel rilievo di immagini radiografiche e/o in terapie per irraggiamento.
ES2005926A6 (es) Aparato de estimulacion de la piel mediante una senal electromagnetica.
IL66699A0 (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infections diseases of different types with alkaloidcompounds
RU94024335A (ru) Способ лечения рака молочной железы
UA30631A (uk) Спосіб лікування надмірної ваги
GR3006404T3 (de)